| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/18/2023 | COLLEGIUM PHARMACEUTICAL, INC | COLL | Grant | Common Stock | 9.8k | $0.00 | $0 | | 05/18/2023 |
| 05/19/2022 | COLLEGIUM PHARMACEUTICAL, INC | COLL | Grant | Common Stock | 14k | $0.00 | $0 | | 05/19/2022 |
| 04/06/2022 | COLLEGIUM PHARMACEUTICAL, INC | COLL | Grant | Common Stock | 17.8k | $0.00 | $0 | | 04/06/2022 |
| 11/24/2021 | Adamas Pharmaceuticals Inc | ADMS | Grant | Common Stock | 75k | $0.00 | $0 | | 11/24/2021 |
| 11/24/2021 | Adamas Pharmaceuticals Inc | ADMS | Other | Common Stock | 600k | $0.00 | $0 | | 11/24/2021 |
| 11/24/2021 | Adamas Pharmaceuticals Inc | ADMS | Disposition | Stock Option (Right to Buy) | 250k | $6.25 | $1.6M | | 11/24/2021 |
| 11/24/2021 | Adamas Pharmaceuticals Inc | ADMS | Disposition | Stock Option (Right to Buy) | 200k | $1.99 | $398k | | 11/24/2021 |
| 03/02/2021 | Adamas Pharmaceuticals Inc | ADMS | Grant | Common Stock | 300k | $0.00 | $0 | | 03/02/2021 |
| 03/18/2020 | Adamas Pharmaceuticals Inc | ADMS | Grant | Stock Option (Right to Buy) | 200k | $1.99 | $398k | | 03/18/2020 |
| 03/18/2020 | Adamas Pharmaceuticals Inc | ADMS | Grant | Common Stock | 100k | $0.00 | $0 | | 03/18/2020 |
| 09/16/2019 | Adamas Pharmaceuticals Inc | ADMS | Grant | Common Stock | 125k | $0.00 | $0 | | 09/16/2019 |
| 09/16/2019 | Adamas Pharmaceuticals Inc | ADMS | Grant | Stock Option (Right to Buy) | 250k | $6.25 | $1.6M | | 09/16/2019 |
| 05/16/2019 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 984 | $18.71 | $18.4k | | 05/15/2019 |
| 05/15/2019 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 984 | $17.78 | $17.5k | | 05/15/2019 |
| 12/20/2018 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 6.4k | $22.56 | $144.5k | | 12/20/2018 |
| 12/20/2018 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 4.7k | $22.00 | $103.9k | | 12/20/2018 |
| 12/18/2018 | Travere Therapeutics, Inc. | RTRX | Grant | Common Stock | 11.1k | $0.00 | $0 | | 12/18/2018 |
| 11/14/2018 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 1000 | $24.64 | $24.6k | | 11/14/2018 |
| 11/14/2018 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 9k | $23.63 | $212.7k | | 11/14/2018 |
| 11/09/2018 | Travere Therapeutics, Inc. | RTRX | Grant | Common Stock | 10k | $0.00 | $0 | | 11/09/2018 |
| 02/08/2018 | Travere Therapeutics, Inc. | RTRX | Grant | Common Stock | 2.5k | $0.00 | $0 | | 02/08/2018 |
| 08/15/2016 | Travere Therapeutics, Inc. | RTRX | Grant | Employee Stock Option (right to buy) | 120k | $17.62 | $2.1M | | 08/15/2016 |
| 08/15/2016 | Travere Therapeutics, Inc. | RTRX | Grant | Common Stock | 15k | $0.00 | $0 | | 08/15/2016 |